Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $12.95, but opened at $13.57. Teladoc Health shares last traded at $13.67, with a volume of 4,377,657 shares trading hands.
Analyst Ratings Changes
A number of research analysts recently weighed in on the stock. Barclays lifted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. TD Cowen dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. The Goldman Sachs Group assumed coverage on shares of Teladoc Health in a report on Friday, November 15th. They issued a “buy” rating and a $14.00 price objective for the company. Royal Bank of Canada lifted their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $11.97.
View Our Latest Stock Report on TDOC
Teladoc Health Trading Down 6.2 %
Insider Activity at Teladoc Health
In related news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.95% of the stock is owned by insiders.
Institutional Investors Weigh In On Teladoc Health
Hedge funds and other institutional investors have recently made changes to their positions in the company. Mitsubishi UFJ Trust & Banking Corp boosted its stake in Teladoc Health by 1,363.0% during the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 33,225 shares of the health services provider’s stock valued at $302,000 after purchasing an additional 30,954 shares during the period. Vanguard Group Inc. grew its position in Teladoc Health by 5.9% in the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after purchasing an additional 1,029,829 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Teladoc Health during the fourth quarter valued at about $297,000. American Century Companies Inc. lifted its stake in shares of Teladoc Health by 18.1% in the fourth quarter. American Century Companies Inc. now owns 209,718 shares of the health services provider’s stock valued at $1,906,000 after buying an additional 32,213 shares during the period. Finally, Generali Investments Management Co LLC acquired a new stake in Teladoc Health during the fourth quarter worth about $64,000. 76.82% of the stock is owned by hedge funds and other institutional investors.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
- Five stocks we like better than Teladoc Health
- Business Services Stocks Investing
- Constellation Brands: A Fallen Star or a Hidden Value Play?
- The How And Why of Investing in Oil Stocks
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.